Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16278492rdf:typepubmed:Citationlld:pubmed
pubmed-article:16278492lifeskim:mentionsumls-concept:C0023823lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C2717940lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0522534lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0486616lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0243144lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0597177lld:lifeskim
pubmed-article:16278492lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:16278492pubmed:issue2lld:pubmed
pubmed-article:16278492pubmed:dateCreated2006-1-26lld:pubmed
pubmed-article:16278492pubmed:abstractTextThe ability of human postprandial triacylglycerol-rich lipoproteins (TRLs), isolated after meals enriched in saturated fatty acids (SFAs), n-6 PUFAs, and MUFAs, to inhibit the uptake of 125I-labeled LDL by the LDL receptor was investigated in HepG2 cells. Addition of TRLs resulted in a dose-dependent inhibition of heparin-releasable binding, cell-associated radioactivity, and degradation products of 125I-labeled LDL (P < 0.001). SFA-rich Svedberg flotation rate (Sf) 60-400 resulted in significantly greater inhibition of cell-associated radioactivity than PUFA-rich particles (P = 0.016) and total uptake of 125I-labeled LDL compared with PUFA- and MUFA-rich particles (P < 0.02). Normalization of the apolipoprotein (apo)E but not apoC-III content of the TRLs removed the effect of meal fatty acid composition, and addition of an anti-apoE antibody reversed the inhibitory effect of TRLs on the total uptake of 125I-labeled LDL. Real time RT-PCR showed that the SFA-rich Sf 60-400 increased the expression of genes involved in hepatic lipid synthesis (P < 0.05) and decreased the expression of the LDL receptor-related protein 1 compared with MUFAs (P = 0.008). In conclusion, these findings suggest an alternative or additional mechanism whereby acute fat ingestion can influence LDL clearance via competitive apoE-dependent effects of TRL on the LDL receptor.lld:pubmed
pubmed-article:16278492pubmed:languageenglld:pubmed
pubmed-article:16278492pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:citationSubsetIMlld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16278492pubmed:statusMEDLINElld:pubmed
pubmed-article:16278492pubmed:monthFeblld:pubmed
pubmed-article:16278492pubmed:issn0022-2275lld:pubmed
pubmed-article:16278492pubmed:authorpubmed-author:WilliamsChris...lld:pubmed
pubmed-article:16278492pubmed:authorpubmed-author:LeakeDavid...lld:pubmed
pubmed-article:16278492pubmed:authorpubmed-author:JacksonKim...lld:pubmed
pubmed-article:16278492pubmed:authorpubmed-author:MaitinVatsala...lld:pubmed
pubmed-article:16278492pubmed:authorpubmed-author:YaqoobParveen...lld:pubmed
pubmed-article:16278492pubmed:issnTypePrintlld:pubmed
pubmed-article:16278492pubmed:volume47lld:pubmed
pubmed-article:16278492pubmed:ownerNLMlld:pubmed
pubmed-article:16278492pubmed:authorsCompleteYlld:pubmed
pubmed-article:16278492pubmed:pagination393-403lld:pubmed
pubmed-article:16278492pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:meshHeadingpubmed-meshheading:16278492...lld:pubmed
pubmed-article:16278492pubmed:year2006lld:pubmed
pubmed-article:16278492pubmed:articleTitleSaturated fat-induced changes in Sf 60-400 particle composition reduces uptake of LDL by HepG2 cells.lld:pubmed
pubmed-article:16278492pubmed:affiliationSchool of Food Biosciences, University of Reading, Reading, Berkshire, United Kingdom. k.g.jackson@reading.ac.uklld:pubmed
pubmed-article:16278492pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16278492pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16278492lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16278492lld:pubmed